Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative Bioavailability of Different Eutropin Formulations in Healthy Volunteers
NCT06743997Phase 1Completed
- Sponsor
- LG Chem
- Start
- Jan 2025
- Primary completion
- Apr 2025
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of somatropin in growth hormone deficiency (GHD) (2 arms), sponsored by LG Chem. Primary endpoint: Area Under the Curve from time zero to last measurable concentration. Started Jan 2025; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT06743997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06743997.